Key Laboratory of Green Printing, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, PR China.
University of Chinese Academy of Sciences (UCAS), Beijing 100049, PR China.
J Am Chem Soc. 2024 Jul 17;146(28):19239-19248. doi: 10.1021/jacs.4c04460. Epub 2024 Jul 1.
Advanced in vitro diagnosis technologies are highly desirable in early detection, prognosis, and progression monitoring of diseases. Here, we engineer a multiplex protein biosensing strategy based on the tunable liquid confinement self-assembly of multi-material heterochains, which show improved sensitivity, throughput, and accuracy compared to standard ELISA kits. By controlling the material combination and the number of ligand nanoparticles (NPs), we observe robust near-field enhancement as well as both strong electromagnetic resonance in polymer-semiconductor heterochains. In particular, their optical signals show a linear response to the coordination number of the semiconductor NPs in a wide range. Accordingly, a visible nanophotonic biosensor is developed by functionalizing antibodies on central polymer chains that can identify target proteins attached to semiconductor NPs. This allows for the specific detection of multiple protein biomarkers from healthy people and pancreatic cancer patients in one step with an ultralow detection limit (1 pg/mL). Furthermore, rapid and high-throughput quantification of protein expression levels in diverse clinical samples such as buffer, urine, and serum is achieved by combining a neural network algorithm, with an average accuracy of 97.3%. This work demonstrates that the heterochain-based biosensor is an exemplary candidate for constructing next-generation diagnostic tools and suitable for many clinical settings.
先进的体外诊断技术在疾病的早期检测、预后和进展监测中是非常需要的。在这里,我们设计了一种基于多材料杂链可调液体限制自组装的多重蛋白质生物传感策略,与标准 ELISA 试剂盒相比,该策略显示出了更高的灵敏度、通量和准确性。通过控制材料组合和配体纳米颗粒(NPs)的数量,我们观察到了强近场增强以及聚合物-半导体杂链中的强电磁共振。特别是,它们的光学信号在很宽的范围内对半导体 NPs 的配位数表现出线性响应。因此,通过在中心聚合物链上功能化抗体,开发了一种可见的纳米光子生物传感器,该传感器可以识别附着在半导体 NPs 上的目标蛋白。这使得能够一步检测来自健康人和胰腺癌患者的多种蛋白质生物标志物,检测限低至 1 pg/mL。此外,通过结合神经网络算法,在缓冲液、尿液和血清等多种临床样本中实现了蛋白质表达水平的快速和高通量定量,平均准确率为 97.3%。这项工作表明,基于杂链的生物传感器是构建下一代诊断工具的优秀候选者,适合许多临床环境。